InsidersTradesSigma
Follow the EKF Diagnostics Holdings plc share price and the full insider trade history of the company, a publicly traded company based in United Kingdom. Shares are listed on the UK market, under the oversight of RNS (LSE). Market capitalisation: €110.5m. The latest transaction was filed on 26 March 2025 (Purchase). Among the most active insiders: Harwood Capital LLP and Harwood Capital Management (Gibraltar) Ltd, (the "Investment Managers"). Every trade is accessible without an account.
Analysts rate EKF Diagnostics Holdings plc Strong Buy (bullish), based on 3 analysts. Average price target: £34.67.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
EKF Diagnostics Holdings plc is a company focused on the development and manufacture of medical diagnostic devices. It specializes in solutions for laboratory medicine and point-of-care healthcare.